“Here, we present a case of metastatic ASCP with a KRAS G12C mutation refractory to multiple lines of systemic therapy, including platinum-based chemotherapy and targeted inhibition of KRAS G12C.” ...
A study using organoids derived from patients' pancreatic cancer tissues revealed that a subset of highly aggressive form of pancreatic cancer, called adenosquamous carcinoma, develop from a less ...
In contrast to other commonly-diagnosed cancers like colorectal and lung cancer, the five-year survival rate after diagnosis for pancreatic cancer is alarmingly low, at 8.5% in Japan. Identity changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results